{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:05:26Z","timestamp":1793315126517,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001738"],"award-info":[{"award-number":["82001738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003363"],"award-info":[{"award-number":["82003363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073449"],"award-info":[{"award-number":["82073449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.phrs.2022.106057","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T03:25:37Z","timestamp":1641353137000},"page":"106057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR\/Smad2\/3 signaling"],"prefix":"10.1016","volume":"176","author":[{"given":"Jiani","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixin","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangfan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuotong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangfan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingsi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10103","key":"10.1016\/j.phrs.2022.106057_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phrs.2022.106057_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2022.106057_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 Years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut Liver"},{"issue":"9","key":"10.1016\/j.phrs.2022.106057_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222779","article-title":"Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor","volume":"14","author":"Hammond","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2022.106057_bib5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.biopha.2017.11.028","article-title":"Esomeprazole ameliorates CCl(4) induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers","volume":"97","author":"Eltahir","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2022.106057_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12967-015-0614-x","article-title":"Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis","volume":"13","author":"Ghebremariam","year":"2015","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.phrs.2022.106057_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1164\/rccm.201512-2316PP","article-title":"Idiopathic pulmonary fibrosis: novel concepts of proton pump inhibitors as antifibrotic drugs","volume":"193","author":"Ghebre","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.phrs.2022.106057_bib8","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3748\/wjg.v23.i9.1586","article-title":"Proton pump inhibitor induced collagen expression in colonocytes is associated with collagenous colitis","volume":"23","author":"Mori","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106057_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2017.12.003","article-title":"The aryl hydrocarbon receptor in the crossroad of signalling networks with therapeutic value","volume":"185","author":"Roman","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2022.106057_bib10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1039\/C4TX00236A","article-title":"Ah receptor pathway intricacies; signaling through diverse protein partners and DNA-motifs","volume":"4","author":"Jackson","year":"2015","journal-title":"Toxicol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106057_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41577-019-0125-8","article-title":"The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease","volume":"19","author":"Rothhammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2022.106057_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105180","article-title":"The aryl hydrocarbon receptor: an environmental effector in the pathogenesis of fibrosis","volume":"160","author":"Shi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2022.106057_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106886","article-title":"Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target","volume":"88","author":"Shi","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106057_bib14","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3390\/cancers12082097","article-title":"Omeprazole inhibits glioblastoma cell invasion and tumor growth","volume":"12","author":"Jin","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.phrs.2022.106057_bib15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/tx5005198","article-title":"Omeprazole inhibits pancreatic cancer cell invasion through a nongenomic aryl hydrocarbon receptor pathway","volume":"28","author":"Jin","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.phrs.2022.106057_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1186\/1471-2407-14-498","article-title":"The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis","volume":"14","author":"Jin","year":"2014","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J. Investig. Dermatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106057_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1165\/rcmb.2013-0094TR","article-title":"Animal models of fibrotic lung disease","volume":"49","author":"B. Moore","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2144\/000112729","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"H\u00fcbner","year":"2008","journal-title":"Biotechniques"},{"issue":"10","key":"10.1016\/j.phrs.2022.106057_bib21","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1093\/rheumatology\/keaa200","article-title":"Increased expression of the transforming growth factor \u03b2-inducible gene HIC-5 in systemic sclerosis skin and fibroblasts: a novel antifibrotic therapeutic target","volume":"59","author":"Piera-Velazquez","year":"2020","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib22","first-page":"171","article-title":"The role of myofibroblasts in wound healing","volume":"64","author":"Hinz","year":"2016","journal-title":"Curr. Res. Transl. Med."},{"key":"10.1016\/j.phrs.2022.106057_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105961","article-title":"Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension","volume":"134","author":"Tam","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2022.106057_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","article-title":"Targeting TGF-\u03b2 signaling for the treatment of fibrosis","volume":"68\u201369","author":"Gy\u00f6rfi","year":"2018","journal-title":"Matrix Biol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106057_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.phrs.2022.106057_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1667\/RR15398.1","article-title":"Topical esomeprazole mitigates radiation-induced dermal inflammation and fibrosis","volume":"192","author":"Pham","year":"2019","journal-title":"Radiat. Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/infdis\/jiv184","article-title":"Proton-pump inhibitor exposure aggravates clostridium difficile-associated colitis: evidence from a mouse model","volume":"212","author":"Hung","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2022.106057_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0016-5085(98)70535-9","article-title":"Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis","volume":"114","author":"Mourelle","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106057_bib29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2019.10.016","article-title":"Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway","volume":"318","author":"Hamano","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.phrs.2022.106057_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00281-021-00867-8","article-title":"The aryl hydrocarbon receptor in liver inflammation","volume":"43","author":"Carambia","year":"2021","journal-title":"Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/eji.201445228","article-title":"Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut","volume":"46","author":"Monteleone","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106057_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.bcp.2008.08.019","article-title":"Interaction between the aryl hydrocarbon receptor and transforming growth factor-beta signaling pathways: evidence of an asymmetrical relationship in rat granulosa cells","volume":"76","author":"Bussmann","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106057_bib34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bcp.2008.09.013","article-title":"Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways","volume":"77","author":"Haarmann-Stemmann","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"Pt. 11","key":"10.1016\/j.phrs.2022.106057_bib35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1242\/jcs.047274","article-title":"Loss of dioxin-receptor expression accelerates wound healing in vivo by a mechanism involving TGFbeta","volume":"122","author":"Carvajal-Gonzalez","year":"2009","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.phrs.2022.106057_bib36","first-page":"1066","article-title":"The aryl hydrocarbon receptor agonist benzo(a)pyrene reactivates LINE-1 in HepG2 cells through canonical TGF-\u03b21 signaling: implications in hepatocellular carcinogenesis","volume":"6","author":"Reyes-Reyes","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106057_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-015-0659-5","article-title":"Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis","volume":"17","author":"Ruzehaji","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106057_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2015.04.012","article-title":"Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions","volume":"97","author":"Della Latta","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106057_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.88","article-title":"Experimental mouse model of bleomycin-induced skin fibrosis","volume":"126","author":"B\u0142yszczuk","year":"2019","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.phrs.2022.106057_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4939-7113-8_2","article-title":"The bleomycin model of pulmonary fibrosis","volume":"1627","author":"Liu","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106057_bib41","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.3892\/mmr.2015.3193","article-title":"Inhibition of transforming growth factor-\u03b2 via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis","volume":"11","author":"Koh","year":"2015","journal-title":"Mol. Med. Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:28:02Z","timestamp":1760912882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":41,"alternative-id":["S1043661822000020"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106057","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR\/Smad2\/3 signaling","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106057"}}